Knight Therapeutics Inc. (GUD.TO)
| Previous Close | 5.82 |
| Open | 5.84 |
| Bid | 5.90 x 0 |
| Ask | 5.91 x 0 |
| Day's Range | 5.82 - 5.94 |
| 52 Week Range | 4.35 - 5.95 |
| Volume | |
| Avg. Volume | 69,667 |
| Market Cap | 597.915M |
| Beta (5Y Monthly) | 0.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.16 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.75 |
GlobeNewswireNotice of Knight Therapeutics' First Quarter 2024 Results Conference Call
MONTREAL, May 02, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024 financial results on Thursday, May 9, 2024 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Thursday, May 9, 2024 Time: 8:30 a.m. ET Telephone: Toll Free: 1-800-836-8184 o
Simply Wall St.Knight Therapeutics (TSE:GUD) shareholders have endured a 21% loss from investing in the stock five years ago
For many, the main point of investing is to generate higher returns than the overall market. But even the best stock...
The Motley FoolTSX Healthcare in April 2024: The Best Stocks to Buy Right Now
TSX’s healthcare sector is not as popular as the heavyweight sectors, but it has three of the best stocks you can buy in April. The post TSX Healthcare in April 2024: The Best Stocks to Buy Right Now appeared first on The Motley Fool Canada.
